|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| A61K 39/39 | |||
| A61K 39/00 | |||
| G01N 33/68 | |||
| A61K 48/00 | |||
| A61P 25/28 |
| (11) | Number of the document | 1185298 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00937919.9 |
| Date of filing the European patent application | 2000-05-26 | |
| (97) | Date of publication of the European application | 2002-03-13 |
| (45) | Date of publication and mention of the grant of the patent | 2009-06-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2000/014810 |
| Date | 2000-05-26 |
| (87) | Number | WO 2000/072880 |
| Date | 2000-12-07 |
| (30) | Number | Date | Country code |
| 322289 | 1999-05-28 | US |
| (72) |
SCHENK, Dale, B., US
BARD, Frederique, US
VASQUEZ, Nicki, J., US
YEDNOCK, Ted, US
|
| (73) |
Elan Pharma International Limited,
Monksland, Athlone County Westmeath,
IE
|
| (54) | PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |
| PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE |